Inventor · disambiguated record
Kai Krohn
Also filed as: KROHN KAI · KROHN KAI J E
16 granted patents·7 pending applications·41 citations·filing 1989–2021
91Inventor score
Top patents by PatentIndex Score
23 records- 0187US10131709B2Nucleic acid molecules encoding monoclonal antibodies specific for IL-22IMMUNOQURE AG·Filed 2016·Granted Nov 20, 2018·4 cites·21 claims
- 0283US10081676B2Human anti-IL-32 antibodies and methods of making and using the sameIMMUNOQURE AG·Filed 2014·Granted Sep 25, 2018·4 cites·35 claims
- 0382US7510718B2Expression vectors and uses thereofFIT BIOTECH OYJ PLC·Filed 2002·Granted Mar 31, 2009·11 cites·26 claims
- 0480US9475872B2Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17FIMMUNOQURE AG·Filed 2013·Granted Oct 25, 2016·5 cites·22 claims
- 0579US10112995B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2014·Granted Oct 30, 2018·4 cites·34 claims
- 0676US9957319B2Method of isolating human antibodiesIMMUNOQURE AG·Filed 2013·Granted May 1, 2018·3 cites·14 claims
- 0775US7498314B2Expression vectors and uses thereofFIT BIOTECH OYJ PLC·Filed 2002·Granted Mar 3, 2009·4 cites·64 claims
- 0873US10941198B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2018·Granted Mar 9, 2021·1 cites·30 claims
- 0968US11945861B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2021·Granted Apr 2, 2024·0 cites·23 claims
- 1065US2010203536A1Diagnostics of b-cell lymphomaKROHN KAI·Filed 2008·Application pending·0 cites
- 1162US10875916B2Nucleic acid molecules encoding monoclonal antibodies specific for IL-17FIMMUNOQURE AG·Filed 2018·Granted Dec 29, 2020·0 cites·24 claims
- 1261US2009252707A1Novel expression vectors and uses thereofFIT BIOTECH OY·Filed 2009·Application pending·0 cites
- 1359US2012058108A1Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genesKROHN KAI·Filed 2009·Application pending·0 cites
- 1455US9725486B2Methods of treating HIV diseases using novel expression vectorsFIT BIOTECH OY·Filed 2014·Granted Aug 8, 2017·0 cites·15 claims
- 1554US10975144B2CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibodyIMMUNOQURE AG·Filed 2018·Granted Apr 13, 2021·0 cites·20 claims
- 1653US2013079386A1Diagnostics of b-cell lymphomaHELSINGIN YLIOPISTON RAHASTOT·Filed 2012·Application pending·0 cites
- 1747US7785789B2Gene defective in APECED and its useFINNISH IMMUNOTECHNOLOGY LTD·Filed 2006·Granted Aug 31, 2010·0 cites·6 claims
- 1847US2010143907A1Methods and uses involving genetic abnormalities at chromosome 12KROHN KAI·Filed 2006·Application pending·0 cites
- 1942US2013029337A1Methods and uses involving genetic abnormalities at chromosome 12HELSINGIN YLIOPISTON RAHASTOT·Filed 2012·Application pending·0 cites
- 2040US2016083798A1Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genesValipharma·Filed 2015·Application pending·0 cites
- 2139US8143029B2Methods and means related to diseasesRANKI ANNAMARI·Filed 2006·Granted Mar 27, 2012·0 cites·9 claims
- 2237US6290963B1Anti-HIV compositions containing native and recombinant peptidesUS HEALTH·Filed 1989·Granted Sep 18, 2001·5 cites·8 claims
- 2320US7217806B1Gene defective in APECED and its useFINNISH IMMUNOTECHNOLOGY LTD·Filed 1998·Granted May 15, 2007·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Kai Krohn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →